Next Article in Journal
Design and Synthesis of Analogues of Marine Natural Product Galaxamide, an N-methylated Cyclic Pentapeptide, as Potential Anti-Tumor Agent in Vitro
Next Article in Special Issue
Extracellular Metabolites from Industrial Microalgae and Their Biotechnological Potential
Previous Article in Journal
A Coral-Derived Compound Improves Functional Recovery after Spinal Cord Injury through Its Antiapoptotic and Anti-Inflammatory Effects
Previous Article in Special Issue
Screening of Diatom Strains and Characterization of Cyclotella cryptica as A Potential Fucoxanthin Producer
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2016, 14(9), 159; doi:10.3390/md14090159

Antimicrobial Compounds from Eukaryotic Microalgae against Human Pathogens and Diseases in Aquaculture

1
FR CNRS 3473 IUML Mer-Molécules-Santé (MMS), Université du Maine, Avenue O. Messiaen, Le Mans 72085, France
2
Ifremer, SG2M-LGPMM, Laboratoire de Génétique et de Pathologie des Mollusques Marins, Avenue Mus de Loup, La Tremblade 17390, France
3
Institut des Sciences de la Mer de Rimouski, Université du Québec à Rimouski, 310 des Ursulines, Rimouski, QC G5L 3A1, Canada
4
UMR CNRS 6283 Institut des Molécules et Matériaux du Mans (IMMM), Université du Maine, Avenue O. Messiaen, Le Mans 72085, France
*
Author to whom correspondence should be addressed.
Academic Editor: Peer B. Jacobson
Received: 12 July 2016 / Revised: 20 August 2016 / Accepted: 24 August 2016 / Published: 2 September 2016
(This article belongs to the Collection Bioactive Compounds from Marine Plankton)
View Full-Text   |   Download PDF [1012 KB, uploaded 2 September 2016]   |  

Abstract

The search for novel compounds of marine origin has increased in the last decades for their application in various areas such as pharmaceutical, human or animal nutrition, cosmetics or bioenergy. In this context of blue technology development, microalgae are of particular interest due to their immense biodiversity and their relatively simple growth needs. In this review, we discuss about the promising use of microalgae and microalgal compounds as sources of natural antibiotics against human pathogens but also about their potential to limit microbial infections in aquaculture. An alternative to conventional antibiotics is needed as the microbial resistance to these drugs is increasing in humans and animals. Furthermore, using natural antibiotics for livestock could meet the consumer demand to avoid chemicals in food, would support a sustainable aquaculture and present the advantage of being environmentally friendly. Using natural and renewable microalgal compounds is still in its early days, but considering the important research development and rapid improvement in culture, extraction and purification processes, the valorization of microalgae will surely extend in the future. View Full-Text
Keywords: biological activity; antimicrobial; antibacterial; antifungal; antiviral; biological activity; Haslea; microalgae; sustainable aquaculture biological activity; antimicrobial; antibacterial; antifungal; antiviral; biological activity; Haslea; microalgae; sustainable aquaculture
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Falaise, C.; François, C.; Travers, M.-A.; Morga, B.; Haure, J.; Tremblay, R.; Turcotte, F.; Pasetto, P.; Gastineau, R.; Hardivillier, Y.; Leignel, V.; Mouget, J.-L. Antimicrobial Compounds from Eukaryotic Microalgae against Human Pathogens and Diseases in Aquaculture. Mar. Drugs 2016, 14, 159.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top